Ticker > IPO > SME IPO > SME IPO Listed > Goldline Pharmaceutical

Goldline Pharmaceutical IPO

DRHP

Open Demat Account

Goldline Pharmaceutical IPO Details

Check out the issue details for Goldline Pharmaceutical IPO as disclosed in SEBI.

IPO Price

₹ 43

Price Band

₹ 41 - 43

Issue Size

12.00 Cr.

Issue Type

Book Built

Open

2026-05-12

2026-05-14

Listing price

₹ 59.75

Listing Gain

38.95%

Listing Date

2026-05-19

CMP

₹ 56.77

Current Return

32.02%

Goldline Pharmaceutical coming with IPO to raise up to Rs 11.61 crore11 May 2026, 12:35PM

You can get the following financial statements of Goldline Pharmaceutical as of now.

Company Name

Exchange

BSE: 544759

PARTICULARS	Mar 2023	Mar 2024	Mar 2025
Net Sales	19.85	23.57	28.06
Total Expenditure	17.64	19.26	22
Operating Profit	2.21	4.3	6.06
Other Income	0	0	0
Interest	1.63	1.61	1.95
Depreciation	0.18	0.16	0.25
Exceptional Items	0	0	0
Profit Before Tax	0.4	2.53	3.86
Provision for Tax	0.14	0.72	1.02
Net Profit	0.26	1.81	2.83
Adjusted EPS (Rs.)	0.04	0.26	0.41

Particulars	Mar 2023	Mar 2024	Mar 2025
Equity and Liabilities
Share Capital	3.81	4.11	8.71
Total Reserves	2.08	3.76	1.65
Borrowings	3.81	4.05	3.19
Other N/C liabilities	0.69	0.85	0.97
Current liabilities	9	10.17	11.77
Total Liabilities	19.39	22.93	26.28
Assets
Net Block	2.5	2.95	2.89
Capital WIP	0	0.45	0
Intangible WIP	0	0	0
Investments	0.07	0.03	0.04
Loans & Advances	0	0	0
Other N/C Assets	0	0	0
Current Assets	16.82	19.5	23.35
Total Assets	19.39	22.93	26.28

* Other Non-current Liabilities include Net deferred Liabilities

PARTICULARS	Mar 2023	Mar 2024	Mar 2025
Profit from operations	0.4	2.53	3.86
Adjustment	2	1.82	2.07
Changes in Assets & Liabilities	0.03	-1.23	-2.69
Tax Paid	-0.04	-0.2	-0.91
Operating Cash Flow	2.39	2.92	2.32
Investing Cash Flow	-1.03	-1.11	0.16
Financing Cash Flow	-1.44	-1.08	-2.03
Net Cash Flow	-0.09	0.74	0.45